IPR Estoppel Does Not Bar Commission Investigative Staff from Asserting Prior Art References in an ITC Investigation

Oct 15, 2018

Reading Time : 1 min

The estoppel provision of 35 U.S.C. § 315(e)(2) prohibits the “petitioner . . .[,] real party in interest or privy of the petitioner” from raising grounds of invalidity that were “raised or reasonably could have [been] raised, during [IPR]” in a district court litigation or an investigation before the ITC.   

Prior to the instant ITC investigation, respondent Fujifilm had petitioned for IPR of one of Sony’s patents. The PTAB instituted review of the patent, but determined (in its final written decision) that it was not unpatentable. In the ITC investigation, Sony asserted the same patent against Fujifilm and contended that Fujifilm was estopped from relying on prior art references asserted in the IPR.

Sony also went one step further by arguing that the Commission Investigative Staff were estopped from asserting Fujifilm’s IPR references. In response, the Staff argued that 35 U.S.C. § 315(e)(2) “only estops the petitioner in an inter partes review,” and further that it was not a petitioner or even a party to the IPR. The ALJ found the Staff’s argument persuasive and held that “Regardless of whether 35 U.S.C. § 315(e)(2) estops Fujifilm, as contended by Sony, the statute does not prevent Staff from raising the references in this investigation, which it did.”  With the estoppel issue resolved, ALJ Cheney addressed the prior art references and found the asserted claims of the Sony patent invalid for anticipation and obviousness.  

Practice Tip:  Patent owners should be cognizant that, in ITC investigations, the estoppel provision of 35 U.S.C. § 315(e)(2) has been interpreted as being strictly limited to the petitioner, the real parties-in-interest or privies of the petitioner—but not encompassing the Commission Investigative Staff. This leaves open the possibility of the Staff raising invalidity challenges that have been previously rejected by the PTAB.

In the Matter of Certain Magnetic Tape Cartridges and Components Thereof, 337-TA-1058 (ITC October 2, 2018, Order) (Cheney, ALJ).

Share This Insight

Previous Entries

IP Newsflash

February 20, 2026

The Federal Circuit recently addressed whether the PTO must conduct notice‑and‑comment rulemaking before issuing instructions that guide how the Board should exercise discretion at the institution stage of IPRs. The court held that no such rulemaking is required. Instructions to the Board regarding its use of the Director’s delegated discretionary authority not to institute review are merely general statements of policy exempt from notice-and-comment rulemaking.  

...

Read More

IP Newsflash

February 18, 2026

The District Court for the District of Delaware recently invalidated claims directed to a panoramic objective lens for lack of enablement, holding the claims impermissibly recited a single element in means‑plus‑function form. Under § 112, ¶ 6, “[a]n element in a claim for a combination may be expressed as a means or step for performing a specified function….” By its plain terms, the statute permits means‑plus‑function claiming only in the context of a “combination.” In other words, a claim may not consist solely of a single means‑plus‑function element. Claims drafted as a single means are invalid for lack of enablement as a matter of law.

...

Read More

IP Newsflash

February 13, 2026

In an ANDA litigation, the District of Delaware recently denied the defendants’ motion to compel the production of correspondence between the plaintiffs’ testifying expert and a third-party analyst who had performed experiments and provided data used by the testifying expert. The court found that the scope of material sought by the motion was overbroad and disproportionate to the needs of the case.

...

Read More

IP Newsflash

February 12, 2026

In an ANDA litigation, the District of Delaware recently denied the plaintiffs’ motion to strike portions of the defendants’ expert reports and related deposition testimony. Although the defendants’ invalidity contentions did not state the specific theories of invalidity upon which the expert opined, the court found that none of the Pennypack factors supported excluding that expert testimony.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.